BioNexus Gene Lab (BGLC) Other Non Operating Income (2019 - 2026)
BioNexus Gene Lab recorded quarterly Other Non Operating Income of $57686.0 in Q1 2026, up 145.72% quarter-over-quarter from $23476.0 in Q4 2025, and down 36.9% year-over-year from $91420.0 in Q1 2025.
BioNexus Gene Lab's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $57686.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 36.9% year-over-year to $57686.0; the TTM figure through Mar 2026 stood at $398383.0 (down 79.7% YoY), while the FY2025 annual figure was $432117.0, down 79.15% from the prior year.
- Other Non Operating Income came in at $57686.0 for Q1 2026 at BioNexus Gene Lab, up from $23476.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $730105.0 in Q2 2024 to a low of -$68776.0 in Q1 2022.
- A 4-year average of $249350.0 and a median of $154803.5 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 67.01% in 2022 and tumbled 96.52% in 2025, its largest moves.
- BioNexus Gene Lab's Other Non Operating Income stood at -$68776.0 in 2022, then jumped by 1081.44% to $674994.0 in 2024, then sank by 96.52% to $23476.0 in 2025, then jumped by 145.72% to $57686.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $57686.0, $23476.0, and $107760.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,686.00 |
| Dec 31, 2025 | 23,476.00 |
| Sep 30, 2025 | 107,760.00 |
| Jun 30, 2025 | 209,461.00 |
| Mar 31, 2025 | 91,420.00 |
| Dec 31, 2024 | 674,994.00 |
| Sep 30, 2024 | 465,527.00 |
| Jun 30, 2024 | 730,105.00 |
| Mar 31, 2024 | 201,847.00 |
| Mar 31, 2022 | -68,776.00 |
| Dec 31, 2021 | 38,930.00 |
| Sep 30, 2021 | -56,940.00 |
| Jun 30, 2021 | -7,468.00 |
| Mar 31, 2021 | -208,468.00 |
| Dec 31, 2020 | 153,855.00 |
| Sep 30, 2020 | 248,070.00 |
| Jun 30, 2020 | 43,558.00 |
| Mar 31, 2020 | -294,696.00 |
| Dec 31, 2019 | 21,130.00 |
| Sep 30, 2019 | -10,802.00 |
| Jun 30, 2019 | -17,600.00 |
| Mar 31, 2019 | 17,145.00 |